Cargando…
HDMTX-based induction therapy followed by consolidation with conventional systemic chemotherapy and intraventricular therapy (modified Bonn protocol) in primary CNS lymphoma: a monocentric retrospective analysis
BACKGROUND: To evaluate outcome and toxicity of High-dose methotrexate (HDMTX)-based induction therapy followed by consolidation with conventional systemic chemotherapy and facultative intraventricular therapy (modified Bonn protocol) in patients with primary CNS lymphoma (PCNSL). METHODS: Between 0...
Autores principales: | Seidel, Sabine, Korfel, Agnieszka, Kowalski, Thomas, Margold, Michelle, Ismail, Fatme, Schroers, Roland, Baraniskin, Alexander, Pels, Hendrik, Martus, Peter, Schlegel, Uwe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7650117/ https://www.ncbi.nlm.nih.gov/pubmed/33324883 http://dx.doi.org/10.1186/s42466-019-0024-2 |
Ejemplares similares
-
HDMTX-based polychemotherapy including intraventricular therapy in
elderly patients with primary CNS lymphoma: a single center
series
por: Seidel, Sabine, et al.
Publicado: (2020) -
Patients with Primary Central Nervous System Lymphoma Not Eligible for Clinical Trials: Prognostic Factors, Treatment and Outcome
por: Seidel, Sabine, et al.
Publicado: (2021) -
The value of bone marrow biopsy for staging of patients with primary CNS lymphoma
por: Margold, Michelle, et al.
Publicado: (2021) -
Twenty-year follow-up of a pilot/phase II trial on the Bonn protocol for primary CNS lymphoma
por: Seidel, Sabine, et al.
Publicado: (2020) -
High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation in Relapsed or Refractory Primary CNS Lymphoma: A Retrospective Monocentric Analysis of Long-Term Outcome, Prognostic Factors, and Toxicity
por: Seidel, Sabine, et al.
Publicado: (2022)